Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025
Medifast (NYSE: MED), the company behind the OPTAVIA® health and wellness lifestyle solution, has scheduled its first quarter 2025 financial results announcement for Monday, April 28, 2025, after market close.
The company will host a conference call at 4:30 p.m. ET featuring Chairman and CEO Dan Chard and CFO Jim Maloney. The call will be accessible via live webcast on Medifast's Investor Relations website and will remain archived through July 28, 2025.
Telephone participants can join by dialing (201) 389-0879, with playback available from 8:30 p.m. ET on April 28 through May 5, 2025, using access code 13752614.
Medifast (NYSE: MED), l'azienda dietro la soluzione per uno stile di vita sano e benessere OPTAVIA®, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per lunedì 28 aprile 2025, dopo la chiusura del mercato.
L'azienda terrà una conference call alle 16:30 ET con la partecipazione del Presidente e CEO Dan Chard e del CFO Jim Maloney. La chiamata sarà accessibile tramite webcast in diretta sul sito delle Relazioni con gli Investitori di Medifast e resterà archiviata fino al 28 luglio 2025.
I partecipanti telefonici potranno collegarsi componendo il numero (201) 389-0879, con la possibilità di ascoltare la registrazione dalle 20:30 ET del 28 aprile fino al 5 maggio 2025, utilizzando il codice di accesso 13752614.
Medifast (NYSE: MED), la empresa detrás de la solución de estilo de vida saludable y bienestar OPTAVIA®, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el lunes 28 de abril de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 p.m. ET con la participación del presidente y CEO Dan Chard y el CFO Jim Maloney. La llamada estará disponible vía webcast en vivo en el sitio web de Relaciones con Inversores de Medifast y permanecerá archivada hasta el 28 de julio de 2025.
Los participantes telefónicos pueden unirse llamando al (201) 389-0879, con reproducción disponible desde las 8:30 p.m. ET del 28 de abril hasta el 5 de mayo de 2025, usando el código de acceso 13752614.
Medifast (NYSE: MED)는 OPTAVIA® 건강 및 웰니스 라이프스타일 솔루션을 제공하는 회사로, 2025년 1분기 재무 결과 발표를 2025년 4월 28일 월요일 장 마감 후로 예정했습니다.
회사는 회장 겸 CEO인 Dan Chard와 CFO Jim Maloney가 참여하는 컨퍼런스 콜을 동부시간 오후 4시 30분에 개최할 예정입니다. 이 콜은 Medifast 투자자 관계 웹사이트를 통해 라이브 웹캐스트로 제공되며, 2025년 7월 28일까지 아카이브로 남아있습니다.
전화 참가자는 (201) 389-0879로 전화해 참여할 수 있으며, 재생은 4월 28일 오후 8시 30분(동부시간)부터 2025년 5월 5일까지 접근 코드 13752614를 사용해 가능합니다.
Medifast (NYSE : MED), la société à l’origine de la solution de style de vie santé et bien-être OPTAVIA®, a prévu l’annonce des résultats financiers du premier trimestre 2025 pour le lundi 28 avril 2025, après la clôture du marché.
La société organisera une conférence téléphonique à 16h30 ET avec le président-directeur général Dan Chard et le directeur financier Jim Maloney. L’appel sera accessible via un webcast en direct sur le site des relations investisseurs de Medifast et restera archivé jusqu’au 28 juillet 2025.
Les participants par téléphone peuvent se joindre en composant le (201) 389-0879, avec une lecture disponible à partir de 20h30 ET le 28 avril jusqu’au 5 mai 2025, en utilisant le code d’accès 13752614.
Medifast (NYSE: MED), das Unternehmen hinter der OPTAVIA® Gesundheits- und Wellness-Lifestyle-Lösung, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Montag, den 28. April 2025, nach Börsenschluss, geplant.
Das Unternehmen veranstaltet eine Telefonkonferenz um 16:30 Uhr ET mit Chairman und CEO Dan Chard sowie CFO Jim Maloney. Der Anruf ist über einen Live-Webcast auf der Investor-Relations-Website von Medifast zugänglich und bleibt bis zum 28. Juli 2025 archiviert.
Telefonteilnehmer können sich unter der Nummer (201) 389-0879 einwählen; die Wiedergabe ist von 20:30 Uhr ET am 28. April bis zum 5. Mai 2025 mit dem Zugangscode 13752614 verfügbar.
- None.
- None.
The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1712969&tp_key=ee624f7cf7 and will be archived online and available through July 28, 2025. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 8:30 p.m. ET, April 28, 2025, through May 5, 2025. Participants can dial (412) 317-6671 and enter access code 13752614 to hear the playback.
About Medifast®
Medifast (NYSE: MED) is the 40+ year old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. Through the company’s collaboration with national virtual primary care provider LifeMD® (Nasdaq: LFMD) and its affiliated medical group, customers now have access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature™. Visit MedifastInc.com and OPTAVIA.com for more information and follow Medifast on X and LinkedIn.
MED-F
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414332325/en/
Investor Contact:
Medifast, Inc.
Steven Zenker
InvestorRelations@medifastinc.com
(443) 379-5256
Source: Medifast
FAQ
When will Medifast (MED) release Q1 2025 earnings?
How can investors access Medifast's (MED) Q1 2025 earnings call?
Who will present during Medifast's (MED) Q1 2025 earnings call?
How long will Medifast's (MED) Q1 2025 earnings call recording be available?
